The metabolic cost of childhood ALL

Abstract

In this issue of Blood,Oudin and colleagues report an increased prevalence of the metabolic syndrome (MS) in a cohort of adult survivors of childhood leukemia.1 The coupling of a growing population of maturing childhood leukemia survivors with a syndrome that predisposes to cardiovascular disease, diabetes, and premature mortality is a call to arms for those clinicians who provide long-term care to survivors of childhood cancer.